419 related articles for article (PubMed ID: 14631561)
1. Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up.
Chen S; Jim B; Ziyadeh FN
Semin Nephrol; 2003 Nov; 23(6):532-43. PubMed ID: 14631561
[TBL] [Abstract][Full Text] [Related]
2. The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy.
Chen S; Hong SW; Iglesias-de la Cruz MC; Isono M; Casaretto A; Ziyadeh FN
Ren Fail; 2001; 23(3-4):471-81. PubMed ID: 11499562
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the transforming growth factor-β system in the pathogenesis of diabetic nephropathy.
Ziyadeh FN; Isono M; Chen S
Clin Exp Nephrol; 2002 Sep; 6(3):125-9. PubMed ID: 24989950
[TBL] [Abstract][Full Text] [Related]
4. Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator.
Ziyadeh FN
J Am Soc Nephrol; 2004 Jan; 15 Suppl 1():S55-7. PubMed ID: 14684674
[TBL] [Abstract][Full Text] [Related]
5. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
[TBL] [Abstract][Full Text] [Related]
6. 17beta-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-beta protein expression and signaling.
Dixon A; Maric C
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1678-90. PubMed ID: 17686959
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
Ziyadeh FN; Wolf G
Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
[TBL] [Abstract][Full Text] [Related]
8. Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice.
Sharma K; Jin Y; Guo J; Ziyadeh FN
Diabetes; 1996 Apr; 45(4):522-30. PubMed ID: 8603776
[TBL] [Abstract][Full Text] [Related]
9. Growth factor ultrafiltration in experimental diabetic nephropathy contributes to interstitial fibrosis.
Wang SN; Hirschberg R
Am J Physiol Renal Physiol; 2000 Apr; 278(4):F554-60. PubMed ID: 10751215
[TBL] [Abstract][Full Text] [Related]
10. Potential role of TGF-beta in diabetic nephropathy.
Hoffman BB; Sharma K; Ziyadeh FN
Miner Electrolyte Metab; 1998; 24(2-3):190-6. PubMed ID: 9525704
[TBL] [Abstract][Full Text] [Related]
11. Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy.
Wang S; Denichilo M; Brubaker C; Hirschberg R
Kidney Int; 2001 Jul; 60(1):96-105. PubMed ID: 11422741
[TBL] [Abstract][Full Text] [Related]
12. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy.
Wang SN; LaPage J; Hirschberg R
Kidney Int; 2000 Mar; 57(3):1002-14. PubMed ID: 10720953
[TBL] [Abstract][Full Text] [Related]
13. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis.
Riser BL; Denichilo M; Cortes P; Baker C; Grondin JM; Yee J; Narins RG
J Am Soc Nephrol; 2000 Jan; 11(1):25-38. PubMed ID: 10616837
[TBL] [Abstract][Full Text] [Related]
14. Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells.
Isono M; Chen S; Hong SW; Iglesias-de la Cruz MC; Ziyadeh FN
Biochem Biophys Res Commun; 2002 Sep; 296(5):1356-65. PubMed ID: 12207925
[TBL] [Abstract][Full Text] [Related]
15. FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy.
Loeffler I; Liebisch M; Allert S; Kunisch E; Kinne RW; Wolf G
Cell Tissue Res; 2018 Apr; 372(1):115-133. PubMed ID: 29209813
[TBL] [Abstract][Full Text] [Related]
16. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
[TBL] [Abstract][Full Text] [Related]
17. GLUT1 regulation of the pro-sclerotic mediators of diabetic nephropathy.
Heilig CW; Deb DK; Abdul A; Riaz H; James LR; Salameh J; Nahman NS
Am J Nephrol; 2013; 38(1):39-49. PubMed ID: 23817135
[TBL] [Abstract][Full Text] [Related]
18. Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy.
Kelly DJ; Gilbert RE; Cox AJ; Soulis T; Jerums G; Cooper ME
J Am Soc Nephrol; 2001 Oct; 12(10):2098-2107. PubMed ID: 11562408
[TBL] [Abstract][Full Text] [Related]
19. Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria.
Wang A; Ziyadeh FN; Lee EY; Pyagay PE; Sung SH; Sheardown SA; Laping NJ; Chen S
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1657-65. PubMed ID: 17804483
[TBL] [Abstract][Full Text] [Related]
20. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.
Ziyadeh FN; Hoffman BB; Han DC; Iglesias-De La Cruz MC; Hong SW; Isono M; Chen S; McGowan TA; Sharma K
Proc Natl Acad Sci U S A; 2000 Jul; 97(14):8015-20. PubMed ID: 10859350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
